Major pharma companies spent more on lobbying in third quarter

Pfizer, Novartis, Amgen, Eli Lilly and Johnson & Johnson — typically the top congressional lobbying spenders among the major biopharma companies — generally spent more in the third quarter of this year than a year ago, according ...